The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle

scientific article published on December 1984

The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.7326/0003-4819-101-6-825
P698PubMed publication ID6388454

P2093author name stringGoldman L
Cook EF
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectheart diseaseQ190805
coronary artery diseaseQ844935
P304page(s)825-836
P577publication date1984-12-01
P1433published inAnnals of Internal MedicineQ564416
P1476titleThe decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle
P478volume101

Reverse relations

cites work (P2860)
Q33615616'Ruling out' myocardial infarction in the coronary care unit
Q3387304231st Bethesda Conference. Emergency Cardiac Care. Task force 1: cardiac arrest
Q68047602A comparison of results of a national cholesterol and blood pressure screening with the NHANES II Study: implications for further emphasis on reducing cardiovascular risk among Americans
Q39606710A neonatal screening approach to the detection of familial hypercholesterolaemia and family-based coronary prevention
Q73498740A population-based approach to cholesterol control
Q33559037A public health approach to cholesterol. Confronting the 'TV-auto-supermarket society'.
Q33548515A review of five major community-based cardiovascular disease prevention programs. Part I: Rationale, design, and theoretical framework.
Q33616750A woman's heart. An update of coronary artery disease risk in women
Q44437511ATP-Sensitive Potassium Channel Traffic Regulation by Adenosine and Protein Kinase C
Q58432502Advancing analytic epidemiologic studies of occupational injuries
Q50632678An age-related difference in the ratio of sudden coronary death over acute myocardial infarction in Estonian males.
Q40482679An update on coronary risk factors
Q42127634Analyzing the decline in the CAD death rate
Q41154173Antioxidants, atherosclerosis and thrombosis.
Q44428785Are increases in treatment levels and Alcoholics Anonymous membership large enough to reduce liver cirrhosis rates?
Q41386366Barriers to lifestyle change, and the need to develop an integrated approach to prevention
Q68919113Blaming the victim: the negative consequence of preventive medicine
Q39281447Cardiovascular care in the urban melting pot.
Q53224795Cardiovascular disease and global health equity: lessons from tuberculosis control then and now.
Q35372621Cardiovascular disease in the Netherlands, 1975 to 1995: decline in mortality, but increasing numbers of patients with chronic conditions
Q34032682Cardiovascular disease: risk factors in older Canadians.
Q68444710Cardiovascular risks: New insights from Framingham
Q35010759Care models and associated outcomes in congenital heart surgery
Q26861748Challenges of ascertaining national trends in the incidence of coronary heart disease in the United States
Q24530105Changing heat-related mortality in the United States
Q50651261Changing patterns of coronary heart disease in the hunter region of New South Wales, Australia.
Q30607849Chin-Shan Community Cardiovascular Cohort in Taiwan-baseline data and five-year follow-up morbidity and mortality
Q33725005Choosing quality of care measures based on the expected impact of improved care on health
Q34191507Clinical Evidence: Emerging approaches in preventing cardiovascular disease.
Q36952970Clinical considerations regarding treatment of hypercholesterolemia in the elderly
Q73512446Comment: Gunsmoke--changing public attitudes toward smoking and firearms
Q71551106Comparison of mortality from acute myocardial infarction in patients receiving anistreplase with those not receiving thrombolysis
Q33718012Consequences of variation in treatment for acute myocardial infarction
Q35371795Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994
Q27012592Contributions of risk factors and medical care to cardiovascular mortality trends
Q42285070Convergence and divergence of life expectancy in Europe: a centennial view
Q57421301Coronary Heart Disease and Hypertension
Q36783038Coronary artery disease. The latest on prevention
Q68720858Coronary heart disease in Massachusetts: the years of change (1980-1984)
Q46610981Coronary risk factors in adult children of parents with coronary heart disease: a comparison survey of southeastern Brazil and southeastern United States
Q67597163Correlates of nonadherence to hypertension treatment in an inner-city minority population
Q41740403Cost-effective strategies for the management of vascular disease
Q37581209Cost-effectiveness perspectives in coronary heart disease
Q37808517Costs and benefits of risk factor reduction for coronary heart disease: insights from screening and treatment of serum cholesterol
Q40424562Cost‐effectiveness of alternative interventions for the prevention and treatment of coronary heart disease
Q44793509Current status of cholesterol treatment in the community: The Minnesota heart survey
Q35185829Death of a heart surgeon: reflections on press accounts of the murder of Victor Chang
Q35696678Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study.
Q40656464Declining cardiovascular disease incidence and environmental components
Q73578234Decreasing mortality from acute myocardial infarctions: effect of attack rates and case severity
Q35002144Decreasing trends in cardiovascular mortality in Turkey between 1988 and 2008.
Q68470624Detection and treatment of hypercholesterolemia in a biethnic community, 1979–1985
Q43818392Development of a structural equation model for causal relationships among arteriosclerosis risk factors
Q94278450Dietary Fats and Coronary Heart Disease
Q67768154Dietary factors in the fall in coronary heart disease mortality
Q67945486Divergence of the recent trends in coronary mortality for the four major race-sex groups in the United States
Q33717288Do cardiologists have higher thresholds for recommending coronary arteriography than family physicians?
Q42579997Does modern medicine increase life-expectancy: Quest for the Moon Rabbit?
Q71716426Effect of a postdischarge education class on coronary artery disease knowledge and self-reported health-promoting behaviors
Q39728963Elevated blood pressure in urban emergency department patients
Q40538399Enlightened individual choice vs the public's health: rational prevention from whose perspective?
Q72702173Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure
Q58390921Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations
Q39654319Ethnicity, socio-economic position and gender--do they affect reported health-care seeking behaviour?
Q33633505Evidence based cardiology: emerging approaches in preventing cardiovascular disease
Q33606250Evidence links increases in public health spending to declines in preventable deaths
Q40721049Exercise and aging. Issues for the practitioner
Q34379641Exercise rehabilitation of older patients with cardiovascular disease
Q57747446Explaining the Decline in Coronary Heart Disease Mortality in Finland between 1982 and 1997
Q84242169Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000
Q69414455Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model
Q37001580Future non-invasive imaging to detect vascular plaque instability and subclinical non-obstructive atherosclerosis
Q46616464Gender differences in coronary angiographic findings from 1972 through 1981 in Los Angeles, California
Q69801856Geographic variation in the onset of decline of male ischemic heart disease mortality in The Netherlands
Q68516033Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias
Q47280659Health behavior changes in the United States, the United Kingdom, and France
Q54937459Heart Disease Death Rates Among Blacks and Whites Aged ≥35 Years - United States, 1968-2015.
Q33717229Heart disease and hospital deaths: an empirical study
Q34784496Hypertension as a risk factor for developing depressive symptoms among community-dwelling elders.
Q39903286Impact of State Public Health Spending on Disease Incidence in the United States from 1980 to 2009.
Q43470619Implications of a Nicotine-Free Society
Q35717087Improved prognosis since 1969 of myocardial infarction treated in a coronary care unit: lack of relation with changes in severity
Q38518073Incidence and case fatality rates of acute myocardial infarction (1975–1984): The Worcester Heart Attack Study
Q36837451Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993.
Q24289253Increasing disparities between resource inputs and outcomes, as measured by certain health deliverables, in biomedical research
Q46880764Increasing evidence-based treatments to reduce coronary heart disease mortality in Sweden: quantifying the potential gains
Q36674340Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States?
Q39263828Ischaemic heart disease among men in Norway during the period 1966-1985: two counties with different mortality time trends
Q33705561Ischaemic heart disease mortality among men in Norway: reversal of urban-rural difference between 1966 and 1989
Q43878234Ischemic heart disease prevention: Estimating the impact of interventions
Q34032688Knowledge and awareness of risk factors for cardiovascular disease among Canadians 55 to 74 years of age: results from the Canadian Heart Health Surveys, 1986-1992.
Q68394192Lengths of stay of patients with uncomplicated acute myocardial infarction at three Boston hospitals: impact of pre-discharge tactics
Q44520744Life-years gained from coronary heart disease mortality reduction in Scotland: prevention or treatment?
Q61192550Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000
Q68603066Long-term impact of smoking cessation on the incidence of coronary heart disease
Q30377539Long-term trends in cardiovascular disease mortality and association with respiratory disease.
Q37301547Long-term trends in myocardial infarction incidence and case fatality in the National Heart, Lung, and Blood Institute's Framingham Heart study
Q44775671Major differences in cardiovascular risk indicators by educational status. Results from a population based screening program
Q43998492Management of mild hypertension
Q33558825Management of mild hypertension. Selecting an antihypertensive regimen
Q34282509Medical management and the decline in mortality from coronary heart disease
Q33789111Medical treatment of the aorta. II.
Q39477119Medicine matters after all
Q94278535Modern Times
Q28142616Mortality and morbidity attributable to use of addictive substances in the United States
Q34405248Mortality and morbidity trends: is there compression of morbidity?
Q33673284Mortality risks in alcoholism and effects of abstinence and addiction treatment
Q34725347Multiple cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group
Q39746267Noninvasive tests for diagnosing the presence and extent of coronary artery disease: exercise electrocardiography, thallium scintigraphy, and radionuclide ventriculography
Q46984994Nutrition knowledge and attitudes of cardiac patients
Q34107618Nutritional interventions in cardiovascular disease: new challenges and opportunities
Q74622208Nutritional interventions to reduce cardiovascular disease: individual versus population perspectives
Q33645696Pharmacoeconomics of lipid-lowering agents for primary and secondary prevention of coronary artery disease
Q46103477Polarities in medicine
Q41715879Prehospital delay in patients with acute coronary heart disease: concordance between patient interviews and medical records
Q38357890Prehypertension--prevalence, health risks, and management strategies
Q37799421Prehypertension: An Opportunity for a New Public Health Paradigm
Q37262225Prehypertension: risk stratification and management considerations
Q37362757Prehypertension: should we be treating with pharmacologic therapy?
Q34032695Prevalence of risk factors for cardiovascular disease in Canadians 55 to 74 years of age: results from the Canadian Heart Health Surveys, 1986-1992
Q68162582Prevention of cardiovascular disease in the elderly
Q74018424Primary care physicians and coronary heart disease prevention: a practice model
Q44106401Program on the surgical control of the hyperlipidemias (POSCH): Patient entry characteristics
Q43554968Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. The Framingham Heart Study
Q90737206Provincial health expenditure and cardiovascular disease mortality, a panel data study of Canadian provinces
Q42259772Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010.
Q40734450Recent time trends in acute myocardial infarction in Stockholm, Sweden
Q41529254Recent trends in acute care hospital utilization in Ontario for diseases of the circulatory system
Q36283171Reducing the Risk of Coronary Artery Disease: Helping patients change
Q58179005Relationship Between Risk Factor Trends and Disease Trends
Q86677956Relationship of self-effecacy to cholesterol lowering and dietary change in hyperlipidemia
Q43758541Relative importance of improved hospital treatment and primary prevention. Results from 20 years of the Myocardial Infarction Register, Göteborg, Sweden
Q41723391Risk factors for coronary heart disease in women
Q33786237Screening for cardiovascular disease. Concepts, conflicts, and consensus
Q43177508Seasonal changes in mortality rates from main causes of death in Japan (1970--1999).
Q75287379Secular decrease in blood pressure and reduction in mortality from cardiovascular disease in Israeli workers
Q26851295Shared care--is it worth it for the patient?
Q33560221Simvastatin: a pharmacoeconomic evaluation of its cost-effectiveness in hypercholesterolaemia and prevention of coronary heart disease
Q38764672Smoking: human and economic costs
Q37808776Stagnant in cardiovascular prevention: alarming trends and persistent socioeconomic obstacles.
Q35411223Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels
Q41268248Task force III: Major demographic and epidemiologic trends affecting adult cardiology
Q47967777Temporal Associations Between Smoking and Cardiovascular Disease, 1971 to 2006 (from the Framingham Heart Study).
Q34761652Temporal trend analysis of avoidable mortality in Taiwan, 1971-2008: overall progress, with areas for further medical or public health investment
Q33821081Temporal trends in medical therapies for ST- and non-ST elevation myocardial infarction: (from the Atherosclerosis Risk in Communities [ARIC] Surveillance Study)
Q35621407The War on Poverty's Experiment in Public Medicine: Community Health Centers and the Mortality of Older Americans
Q53614601The contribution of medical care to mortality decline: McKeown revisited.
Q52937784The decline and rise of coronary heart disease: understanding public health catastrophism.
Q68327122The decline in coronary mortality and medical care: some additional questions
Q34700621The economics of diabetes prevention
Q51572952The effect of age on cardiovascular risk factors in Chinese women.
Q34215500The genetics of atherothrombotic disorders: a clinician's view
Q35920789The health consequences of smoking. Cardiovascular diseases
Q33401729The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999-2010.
Q34102249The impact of preventive cardiology on coronary artery disease
Q72933701The investigation and management of stable angina. Report of a working party of the Joint Audit Committee of the British Cardiac Society and the Royal College of Physicians of London
Q69584316The maturation of a cardiologist with reflections on the "passing sands of time"
Q33855756The prevalence and prognostic significance of electrocardiographic abnormalities
Q39540365The rise and fall of ischemic heart disease in Australia
Q33809060The role of coronary angioplasty and stenting in acute myocardial infarction
Q53454652The role of medical care in contributing to health improvements within societies.
Q46510248The role of risk factor time trends in the steep decline of CHD mortality between two Israeli cohort studies
Q44745301Time trends in the treatment of acute myocardial infarction in Switzerland from 1986 to 1993: do they reflect the advances in scientific evidence from clinical trials?
Q33701313Trends in "avoidable" mortality in Sweden, 1974-1985.
Q34725940Trends in coronary artery bypass grafting in Ontario from 1981 to 1989.
Q28175989Trends in treatment and outcomes for acute myocardial infarction: 1975-1995
Q90678493US trends in premature heart disease mortality over the past 50 years: Where do we go from here?
Q33588350Update in internal medicine
Q37391696Urban-rural differences in coronary heart disease mortality in the United States: 1999-2009.
Q73906497Usefulness of the Killip classification for early risk stratification of patients with acute myocardial infarction in the 1990s compared with those treated in the 1980s. Israeli Thrombolytic Survey Group and the Secondary Prevention Reinfarction Isr
Q35030744Vitamin E in cardiovascular disease: has the die been cast?
Q34068636What contribution has cardiac surgery made to the decline in mortality from coronary heart disease?
Q70335693What contribution has cardiac surgery made to the decline in mortality from coronary heart disease?

Search more.